Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07789899 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Two GSK3862995B Formulations in Healthy Participants

Name: A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Two GSK3862995B Formulations in Healthy Participants — clinical trial record (NCT07789899)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1

SponsorGlaxoSmithKline

Started2026-08-18

View on ClinicalTrials.gov ↗

This study will compare two formulations of the investigational medicine GSK3862995B in healthy adults. The study aims to assess how the body absorbs and processes the medicine, and to evaluate its safety and tolerability.

Trial Details

NCT Number	NCT07789899
Lead Sponsor	GlaxoSmithKline
Conditions	Pulmonary Disease, Chronic Obstructive
Enrollment	24 participants
Start Date	2026-08-18
Primary Completion	2027-09-07 (estimated)
Study Completion	2027-09-07 (estimated)
Updated on ClinicalTrials.gov	2026-09-01